Developer docs
API playgroundTry for free, no card

Search company profiles

PrecisionMed

Full company profile

uuid0009dkr

Namestring
PrecisionMed
Legal namestring
PrecisionMed, Inc.
Company typeenum
Private
Founded yearint
1996
Descriptiontext

PrecisionMed is a US-based human biospecimen supplier operating as a subsidiary of BioIVT since its 2024 acquisition. The company provides pharmaceutical, biotechnology, and academic and government research institutions with high-quality, IRB-approved human biological samples—including cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine—collected longitudinally with detailed HIPAA-compliant clinical metadata. Its core differentiation is the position as the world's largest private global source of longitudinally collected human CSF, anchored by the proprietary TruNormal® control samples that serve as matched controls for diseased material in neuroscience research.

The underlying technology combines a predictive biobanking inventory model with standardized collection and quality control procedures executed through validated clinical sites under US IRB-approved protocols. Samples are annotated with cognitive rating scales, demographics, family history, medical history, and longitudinal treatment data collected prospectively over multiple visits. The portfolio spans three primary verticals—neurology (the flagship CSF and matched biospecimen business), oncology (45,000+ archived FFPE blocks plus paired liquid biopsy collections), and emerging cell and gene therapy support—with a Custom Collections service enabling bespoke procurement for non-standard requests. The current inventory comprises 125,000+ banked samples, 1,500+ individual neurology donors, and 170,000+ guaranteed samples ready to ship.

PrecisionMed monetizes through direct one-time sample sales under a quote-based pricing model with no public rate cards, operating exclusively via direct B2B enterprise sales through its website and sales engagement. Samples ship within days of order and customers retain 100% of sample rights post-purchase with no royalties. The customer base of 600+ institutions globally includes nearly every major pharmaceutical and biotechnology company and named accounts such as Harvard Medical School, Biogen, and GlaxoSmithKline. Marketing and customer acquisition rely on 120+ scientific journal citations referencing PrecisionMed samples, the website Request Inventory form, and a clinical site Partner With Us program, rather than traditional demand-generation channels.

Short descriptiontext

PrecisionMed supplies human biological samples—primarily cerebrospinal fluid, serum, plasma, FFPE tissue, and matched biofluids—to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, and molecular diagnostics. Now a BioIVT subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human biospecimens supply, biorepository services, cerebrospinal fluid samples, biomarker discovery samples, clinical tissue samples
Industry4 codes
PRIMARYHLAAAMAA
Biomarker Discovery & Validation (omics, assay feasibility, clinical validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGACAJ
Clinical Trial Sample Collection & Site Phlebotomy Services
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
NAICS code3 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Biorepository and Biospecimen Supply Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Human Biological Sample Sales
TypeOne Time License
Description

Direct sale of human biological specimens including CSF, serum, plasma, tissue, DNA/RNA, and urine samples to pharmaceutical, biotechnology, and academic researchers. Samples are sold with detailed clinical data and ship immediately upon order.

precisionmed.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1TruNormal®
Description

Proprietary normal control biological samples from donors with normal cognition, no history of significant neurological or neuropsychiatric disease

precisionmed.com
Core offering1 text field

PrecisionMed supplies high-quality human biological samples—primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, urine, and CSF cell pellets—collected longitudinally under US IRB-approved protocols and annotated with detailed HIPAA-compliant clinical data. Its proprietary TruNormal® controls are the world's only commercially available vetted normal control biospecimens. Samples are sold directly to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, molecular diagnostics development, and genetics studies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Samples ship within 3 days of order
+2 more records
Product overview1 text field

PrecisionMed is a human biological sample biorepository and supplier, operating as a subsidiary of BioIVT. Its portfolio centers on high-quality, IRB-approved human biospecimens — primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine — collected longitudinally with detailed clinical data. The core product is its neurology CSF biorepository, the world's largest private global source of diseased and TruNormal control CSF. TruNormal Controls (the world's only supplier of proprietary normal biological samples) serve as matched controls across the portfolio. Sample types span from primary CSF collections and matched biofluids (PAXGene RNA, serum, plasma, blood cell pellet, urine) to FFPE tissue blocks (45,000+ archived) and liquid biopsy paired samples. Oncology samples provide FFPE tissue and matched biofluids for solid tumor research. The portfolio also includes custom collection services and cell/gene therapy support. All samples include detailed donor clinical data (diagnosis, demographics, family history, rating scales) and are available immediately.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

PrecisionMed has been acquired by BioIVT, becoming 'PrecisionMed, a BioIVT Company.' This acquisition integrates PrecisionMed's extensive CSF and neurology sample biorepository into BioIVT's broader portfolio of human biological samples for research. The acquisition enhances BioIVT's position as a leading supplier of high-quality human biological material while maintaining PrecisionMed's brand identity and operations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Boca Biolistics
TypeDirect peer
Description

Supplier of human biospecimens including tissue, biofluids, and cells for research and diagnostics development. Comparable as a multi-specialty biospecimen provider serving pharma, biotech, and academic researchers with annotated samples.

TypeDirect peer
Description

Online marketplace for human biospecimens connecting researchers with healthcare providers supplying tissue, biofluids, and cells. Comparable in business model of supplying diverse human samples to research customers, though iSpecimen uses a marketplace approach versus PrecisionMed's owned biorepository.

TypeDirect peer
Description

Human biospecimen CRO providing tissue, blood, and biofluid samples with clinical data from global clinical sites. Comparable in business model of prospectively collecting and supplying characterized human samples for research and drug discovery.

TypeBroad incumbent
Description

Large life sciences tools company with a biospecimen division (Tissue Solutions) plus broader proteomics and cell biology product lines. Comparable as a parent-level player in biospecimen supply with additional research tools portfolio.

5Tissue Solutions (a Bio-Techne brand)
TypeDirect peer
Description

Supplies human tissue samples and biofluids to researchers globally. Directly comparable in supplying characterized human biospecimens with clinical data to pharma and academic researchers across multiple therapeutic areas.

TypeBroad incumbent
Description

Major CRO offering research models, biospecimens, and preclinical services. Comparable as a large incumbent serving pharma/biotech research needs with biological materials and laboratory services, though biospecimens are a smaller segment within its broader portfolio.

TypeBroad incumbent
Description

Parent company of PrecisionMed and the largest commercial supplier of human biospecimens globally. Directly comparable as both supply human biological samples to pharma/biotech researchers with overlapping product lines including tissues, biofluids, and cells.

TypeDirect peer
Description

Specialized in oncology biospecimens with detailed clinical annotation from cancer patients. Comparable as a specialty biospecimen provider focused on a single therapeutic area (oncology), similar to PrecisionMed's neurology focus.

TypeDirect peer
Description

Global provider of biospecimens and bioanalytic services to pharma/biotech. Directly comparable in supplying characterized human samples with clinical data for biomarker and drug discovery research, with overlapping offerings in tissue, biofluids, and cell products.

TypeEmerging player
Description

Specialized provider of human primary cells, tissues, and biofluids for research. Comparable in supplying characterized human biological materials to research customers, with overlap in tissue and biofluid product categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PrecisionMed

Biorepository and Biospecimen Supply Servicesprecisionmed.com

PrecisionMed supplies human biological samples—primarily cerebrospinal fluid, serum, plasma, FFPE tissue, and matched biofluids—to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, and molecular diagnostics. Now a BioIVT subsidiary.

What PrecisionMed does

PrecisionMed is a US-based human biospecimen supplier operating as a subsidiary of BioIVT since its 2024 acquisition. The company provides pharmaceutical, biotechnology, and academic and government research institutions with high-quality, IRB-approved human biological samples—including cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine—collected longitudinally with detailed HIPAA-compliant clinical metadata. Its core differentiation is the position as the world's largest private global source of longitudinally collected human CSF, anchored by the proprietary TruNormal® control samples that serve as matched controls for diseased material in neuroscience research.

The underlying technology combines a predictive biobanking inventory model with standardized collection and quality control procedures executed through validated clinical sites under US IRB-approved protocols. Samples are annotated with cognitive rating scales, demographics, family history, medical history, and longitudinal treatment data collected prospectively over multiple visits. The portfolio spans three primary verticals—neurology (the flagship CSF and matched biospecimen business), oncology (45,000+ archived FFPE blocks plus paired liquid biopsy collections), and emerging cell and gene therapy support—with a Custom Collections service enabling bespoke procurement for non-standard requests. The current inventory comprises 125,000+ banked samples, 1,500+ individual neurology donors, and 170,000+ guaranteed samples ready to ship.

PrecisionMed monetizes through direct one-time sample sales under a quote-based pricing model with no public rate cards, operating exclusively via direct B2B enterprise sales through its website and sales engagement. Samples ship within days of order and customers retain 100% of sample rights post-purchase with no royalties. The customer base of 600+ institutions globally includes nearly every major pharmaceutical and biotechnology company and named accounts such as Harvard Medical School, Biogen, and GlaxoSmithKline. Marketing and customer acquisition rely on 120+ scientific journal citations referencing PrecisionMed samples, the website Request Inventory form, and a clinical site Partner With Us program, rather than traditional demand-generation channels.

PrecisionMed firmographics

Firmographics
Name
PrecisionMed
Legal name
PrecisionMed, Inc.
Website
https://precisionmed.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
PrecisionMed supplies human biological samples—primarily cerebrospinal fluid, serum, plasma, FFPE tissue, and matched biofluids—to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, and molecular diagnostics. Now a BioIVT subsidiary.
Ownership category
akta.pro rank

PrecisionMed industry classification

Industry
Product category
Biorepository and Biospecimen Supply Services
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAMAA
Biomarker Discovery & Validation (omics, assay feasibility, clinical validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGACAJ
Clinical Trial Sample Collection & Site Phlebotomy Services
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing

Keywords

  • Human biospecimens supply
  • Biorepository services
  • Cerebrospinal fluid samples
  • Biomarker discovery samples
  • Clinical tissue samples

Where PrecisionMed is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PrecisionMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Human Biological Sample Sales: Direct sale of human biological specimens including CSF, serum, plasma, tissue, DNA/RNA, and urine samples to pharmaceutical, biotechnology, and academic researchers. Samples are sold with detailed clinical data and ship immediately upon order.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

PrecisionMed product offering

Product offering

Core offering

PrecisionMed supplies high-quality human biological samples—primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, urine, and CSF cell pellets—collected longitudinally under US IRB-approved protocols and annotated with detailed HIPAA-compliant clinical data. Its proprietary TruNormal® controls are the world's only commercially available vetted normal control biospecimens. Samples are sold directly to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, molecular diagnostics development, and genetics studies.

Product overview

PrecisionMed is a human biological sample biorepository and supplier, operating as a subsidiary of BioIVT. Its portfolio centers on high-quality, IRB-approved human biospecimens — primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, and urine — collected longitudinally with detailed clinical data. The core product is its neurology CSF biorepository, the world's largest private global source of diseased and TruNormal control CSF. TruNormal Controls (the world's only supplier of proprietary normal biological samples) serve as matched controls across the portfolio. Sample types span from primary CSF collections and matched biofluids (PAXGene RNA, serum, plasma, blood cell pellet, urine) to FFPE tissue blocks (45,000+ archived) and liquid biopsy paired samples. Oncology samples provide FFPE tissue and matched biofluids for solid tumor research. The portfolio also includes custom collection services and cell/gene therapy support. All samples include detailed donor clinical data (diagnosis, demographics, family history, rating scales) and are available immediately.

Differentiator

Problem solved

Functional benefit

Brands

  • TruNormal®: Proprietary normal control biological samples from donors with normal cognition, no history of significant neurological or neuropsychiatric disease

Quantifiable outcome

  • Samples ship within 3 days of order
  • +2 more outcomes

Companies that use PrecisionMed

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

PrecisionMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

PrecisionMed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BioIVTflagshipStrategic or Co-development PartnerPrecisionMed has been acquired by BioIVT, becoming 'PrecisionMed, a BioIVT Company.' This acquisition integrates PrecisionMed's extensive CSF and neurology sample biorepository into BioIVT's broader portfolio of human biological samples for research. The acquisition enhances BioIVT's position as a leading supplier of high-quality human biological material while maintaining PrecisionMed's brand identity and operations.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

PrecisionMed competitors and assessment

Company assessment

Direct peers

  • Boca Biolistics: Supplier of human biospecimens including tissue, biofluids, and cells for research and diagnostics development. Comparable as a multi-specialty biospecimen provider serving pharma, biotech, and academic researchers with annotated samples.
  • iSpecimen: Online marketplace for human biospecimens connecting researchers with healthcare providers supplying tissue, biofluids, and cells. Comparable in business model of supplying diverse human samples to research customers, though iSpecimen uses a marketplace approach versus PrecisionMed's owned biorepository.
  • Cureline: Human biospecimen CRO providing tissue, blood, and biofluid samples with clinical data from global clinical sites. Comparable in business model of prospectively collecting and supplying characterized human samples for research and drug discovery.
  • Tissue Solutions (a Bio-Techne brand): Supplies human tissue samples and biofluids to researchers globally. Directly comparable in supplying characterized human biospecimens with clinical data to pharma and academic researchers across multiple therapeutic areas.
  • Indivumed: Specialized in oncology biospecimens with detailed clinical annotation from cancer patients. Comparable as a specialty biospecimen provider focused on a single therapeutic area (oncology), similar to PrecisionMed's neurology focus.
  • Discovery Life Sciences: Global provider of biospecimens and bioanalytic services to pharma/biotech. Directly comparable in supplying characterized human samples with clinical data for biomarker and drug discovery research, with overlapping offerings in tissue, biofluids, and cell products.

Broad incumbents

  • Bio-Techne: Large life sciences tools company with a biospecimen division (Tissue Solutions) plus broader proteomics and cell biology product lines. Comparable as a parent-level player in biospecimen supply with additional research tools portfolio.
  • Charles River Laboratories: Major CRO offering research models, biospecimens, and preclinical services. Comparable as a large incumbent serving pharma/biotech research needs with biological materials and laboratory services, though biospecimens are a smaller segment within its broader portfolio.
  • BioIVT: Parent company of PrecisionMed and the largest commercial supplier of human biospecimens globally. Directly comparable as both supply human biological samples to pharma/biotech researchers with overlapping product lines including tissues, biofluids, and cells.

Emerging players

  • ZenBio: Specialized provider of human primary cells, tissues, and biofluids for research. Comparable in supplying characterized human biological materials to research customers, with overlap in tissue and biofluid product categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PrecisionMed social profiles

Digital presence

PrecisionMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PrecisionMed leadership team

Management profile

Number of profiles

Profiles3 records

PrecisionMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PrecisionMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PrecisionMed

What does PrecisionMed do?

PrecisionMed supplies high-quality human biological samples—primarily cerebrospinal fluid (CSF), serum, plasma, FFPE tissue, DNA/RNA, urine, and CSF cell pellets—collected longitudinally under US IRB-approved protocols and annotated with detailed HIPAA-compliant clinical data. Its proprietary TruNormal® controls are the world's only commercially available vetted normal control biospecimens. Samples are sold directly to pharmaceutical, biotechnology, academic, and government researchers for drug discovery, biomarker research, molecular diagnostics development, and genetics studies.

Is PrecisionMed a public or private company?

PrecisionMed is a private company. It is classified as corporate owned and is currently operating.

When was PrecisionMed founded?

PrecisionMed was founded in 1996. It employs 11 to 50 people.

Where is PrecisionMed based?

PrecisionMed is headquartered in Carlsbad, United States, in the North America region.

How does PrecisionMed make money?

One revenue line is on record: human Biological Sample Sales.

Who are PrecisionMed's main competitors?

Direct peers on record are Boca Biolistics, iSpecimen, Cureline, Tissue Solutions (a Bio-Techne brand), Indivumed and Discovery Life Sciences. Broad incumbents are Bio-Techne, Charles River Laboratories and BioIVT. ZenBio is listed as an emerging player.

Does PrecisionMed have an API?

No public API is recorded for PrecisionMed.

What industry is PrecisionMed in?

PrecisionMed's product category is Biorepository and Biospecimen Supply Services. Its primary akta.pro industry code is HLAAAMAA, Biomarker Discovery & Validation (omics, assay feasibility, clinical validation), with a secondary code of HLAGACAJ, Clinical Trial Sample Collection & Site Phlebotomy Services. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsBioIVT Acquires PrecisionMedBioIVT, a New York-based research partner for drug and diagnostic development, has acquired PrecisionMed, a supplier of human biological material based in Carlsbad, CA. The deal's financial terms were not disclosed, but PrecisionMed will continue its operations from its current headquarters while maintaining its network of donor and collection sites. This acquisition is expected to enhance BioIVT's offerings in personalized biospecimen solutions for the life sciences.European Pharmaceutical ManufacturerBioIVT Acquires PrecisionMedBioIVT has acquired PrecisionMed LLC, a supplier of human biological materials for genetics and drug discovery research. This acquisition adds PrecisionMed's extensive repository of over 170,000 biospecimens to BioIVT's capabilities, aiming to strengthen their supply network for CSF and liquid biopsy products. Financial terms of the transaction were not disclosed.BioivtPress ReleasesBioIVT has acquired PrecisionMed, a leading global provider of biospecimens for neurology and oncology research. The acquisition grants BioIVT access to PrecisionMed's large repository of human cerebrospinal fluid samples and its network of donors and collection sites. Financial details of the transaction were not disclosed.PR NewswireWest-Atlantic Partners Closes Acquisition of PrecisionMed, Inc.West-Atlantic Partners announced on January 13, 2021 the acquisition of PrecisionMed, Inc. from its founders John Flax, MD and Ronald Flax. PrecisionMed operates the world's largest private biorepository of human cerebrospinal fluid and other biological samples for scientific research. The transaction aims to support PrecisionMed's expansion beyond its core neuroscience focus into oncology and additional disease areas.